Treatment-related acute myeloid leukemia

Clinical trials for Treatment-related acute myeloid leukemia explained in plain language.

Never miss a new study

Get alerted when new Treatment-related acute myeloid leukemia trials appear

Sign up with your email to follow new studies for Treatment-related acute myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

Experimental chemo combo aims to help kids with rare secondary blood cancers

Disease control Ongoing

This study tests a chemotherapy drug called CPX-351 (Vyxeos) in 25 patients under 22 years old who have secondary myeloid neoplasms, a type of blood cancer that develops after previous cancer treatment. Participants receive one or two rounds of CPX-351, followed by a stem cell tr…

Matched conditions: TREATMENT-RELATED ACUTE MYELOID LEUKEMIA

Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

Treatment-related acute myeloid leukemia

Get alerted when new Treatment-related acute myeloid leukemia trials appear

Experimental chemo combo aims to help kids with rare secondary blood cancers